Strand Displacement Amplification Market Analysis

  • Report ID: 5259
  • Published Date: Nov 25, 2025
  • Report Format: PDF, PPT

Strand Displacement Amplification Market Segmentation:

Application Segment Analysis

Strand displacement amplification market from the cancer segment is set to observe the highest revenue share of 35% by the end of 2035. One of the key elements fuelling the segment's expansion is the rising incidence of cancer in the world. For instance, China is seeing a higher prevalence of malignancies, according to the data released in March 2022. The number of instances of new cancer in China in 2022 was predicted to be 4,820,000, with lung cancer being the most prevalent type.

End User Segment Analysis

In terms of end users, the diagnostic laboratories segment is poised to account for the largest market share during the time period. The growth of this segment can be ascribed to the increasing values of nucleic acid amplification in the healthcare domain. Additionally, strand displacement amplification technology is being utilized by research laboratories majorly by forensic labs, and is expected to boost the segment growth in the future times.

Our in-depth analysis of the global market includes the following segments:

           Product Type

  • Instruments
  • Reagents & Consumables

           Application

  • Tuberculosis
  • Hepatitis
  • Malaria
  • Influenza
  • Cancer

            End User

  • Hospitals
  • Diagnostics Laboratories

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of strand displacement amplification is assessed at USD 1.68 billion.

The global strand displacement amplification market size surpassed USD 1.61 billion in 2025 and is projected to witness a CAGR of over 4.5%, crossing USD 2.5 billion revenue by 2035.

North America is anticipated to command a 35% share by 2035 in the strand displacement amplification market, underpinned by rising demand for DNA-based testing and adoption of advanced gene-mutation detection technologies.

Key players in the market include Sherlock Biosciences, Lucigen Corporation, Bio-Rad Laboratories Inc., G-Biosciences, New England Bio-Labs, Geno Technologies Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos